Archer® Solid Tumor research panels offer a sensitive targeted sequencing approach for biomarker detection from both liquid and tissue biopsies.

This approach leverages DNA, RNA or ctDNA input types for sensitive characterization of all variant types from low-input clinical research samples.

RNA Input

FusionPlex Lung

FusionPlex Oncology Research

FusionPlex Solid Tumor

FusionPlex Thyroid and Lung

FusionPlex Sarcoma

Immune Repertoire Profiling

ctDNA Input

LiquidPlex

DNA Input

VariantPlex Solid Tumor

VariantPlex Thyroid and Lung

Blood Cancer Research

Archer® Blood Cancer research tests detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS).

This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample.

RNA Input

FusionPlex ALL

FusionPlex Heme V2

FusionPlex Lymphoma

FusionPlex Myeloid

FusionPlex Pan-Heme​

Immune Repertoire Profiling

DNA Input

VariantPlex Core Myeloid

VariantPlex Myeloid